Resumen
Objectives: To systematically review the effectiveness and safety of chlorine dioxide solution and chlorine derivatives used in the prevention or treatment of COVID-19. Methods: This review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) and follows the guidelines provided in the Cochrane Handbook for Systematic Reviews of Interventions. A librarian developed and executed the search strategy; it was further reviewed by two of the authors and complemented by manual search. Randomized clinical trials, quasi-experimental studies, cohort studies, case-control studies, cross-sectional studies, and case reports were included; in vitro or animal studies were excluded. Abstract and full-text screening according to pre-defined eligibility criteria were performed by two reviewers independently using web application Rayyan QCRI. Disagreements on study selection were resolved by a third reviewer. The systematic review protocol was registered in PROSPERO (CRD42020200641). Results: Neither published nor pre-print studies evaluating the use of chlorine dioxide or derivatives on SARS-CoV-2 infection were identified. The only finding was an unpublished observational study registry which has no results released yet. Conclusions: To date, there are no scientific evidence to uphold the use of chlorine dioxide or derivatives as preventive or therapeutic agents against COVID-19.
Título traducido de la contribución | Chlorine dioxide and chlorine derivatives for the prevention or treatment of covid-19: A systematic review |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 605-610 |
Número de páginas | 6 |
Publicación | Revista Peruana de Medicina Experimental y Salud Publica |
Volumen | 37 |
N.º | 4 |
DOI | |
Estado | Publicada - 1 oct. 2020 |
Publicado de forma externa | Sí |
Palabras clave
- COVID-19
- Chlorine Compounds
- Chlorine Dioxide
- Prevention and Control
- SARS-CoV-2 infection (Source: MeSH NLM)
- Severe Acute Respiratory Syndrome Coronavirus 2